Valuation: Olympus Corporation

Market Cap 1,80500Cr 1.14TCr 1.02TCr 942.24Cr 852.7Cr 1.61TCr 1,07800Cr 1.63TCr 11TCr 4.43TCr 57TCr 4.28TCr 4.2TCr P/E 2027 *
17.3x
P/E 2028 * 14.9x
Enterprise Value 1,88900Cr 1.2TCr 1.07TCr 986.09Cr 892.38Cr 1.68TCr 1,12800Cr 1.7TCr 12TCr 4.64TCr 59TCr 4.48TCr 4.39TCr EV / Sales 2027 *
1.75x
EV / Sales 2028 * 1.67x
Free-Float
94.58%
Yield 2027 *
1.8%
Yield 2028 * 1.88%
1 day-2.12%
1 week-3.45%
Current month-15.79%
1 month-16.84%
3 months-0.94%
6 months+10.25%
Current year-15.79%
1 week 10.31
Extreme 10.31
11.11
1 month 10.31
Extreme 10.31
13.24
Current year 8.08
Extreme 8.08
13.72
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 64 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Director/Board Member 59 25/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%-3.45% - - 1.16TCr
+1.04%+3.27%+24.59%+50.54% 25TCr
+3.01%+3.28%+5.11%+13.72% 16TCr
-1.64%+2.59%-6.84%+58.15% 15TCr
-1.68%+3.05%-55.65%-11.61% 6.61TCr
+0.46%+7.70%+10.50%+64.13% 5.16TCr
+0.65%+4.09%-14.18%-11.20% 5.18TCr
+0.12%+2.00%+16.00%+27.70% 5.09TCr
+2.82%+2.17%+22.03%+62.59% 4.88TCr
+3.36%+5.09%+31.39%+79.47% 4.35TCr
Average +0.51%+3.37%+3.66%+37.06% 9.77TCr
Weighted average by Cap. +0.75%+3.20%+6.12%+38.55%

Financials

2027 *2028 *
Net sales 1,08200Cr 684.8Cr 610.23Cr 564.97Cr 511.28Cr 963.26Cr 65TCr 974.68Cr 6.77TCr 2.66TCr 34TCr 2.57TCr 2.52TCr 1,12300Cr 710.39Cr 633.03Cr 586.08Cr 530.38Cr 999.26Cr 67TCr 1.01TCr 7.03TCr 2.76TCr 35TCr 2.66TCr 2.61TCr
Net income 11TCr 67Cr 59Cr 55Cr 50Cr 94Cr 6.3TCr 95Cr 660.28Cr 259.08Cr 3.31TCr 250.4Cr 245.19Cr 12TCr 77Cr 69Cr 64Cr 58Cr 108.34Cr 7.27TCr 109.63Cr 761.89Cr 298.95Cr 3.82TCr 288.94Cr 282.92Cr
Net Debt 8.4TCr 53Cr 47Cr 44Cr 40Cr 75Cr 5.02TCr 76Cr 525.81Cr 206.32Cr 2.64TCr 199.41Cr 195.25Cr 6.55TCr 41Cr 37Cr 34Cr 31Cr 58Cr 3.91TCr 59Cr 409.86Cr 160.82Cr 2.06TCr 155.43Cr 152.2Cr
Projected Income Statement - Annual - Olympus Corporation
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
22/26/22 $10.67 -2.12% 1,09,400
20/26/20 $10.90 +3.42% 1,48,014
19/26/19 $10.54 -0.85% 63,148
16/26/16 $10.63 -2.16% 42,788
15/26/15 $10.87 -1.67% 92,904
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Olympus Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,698.50JPY
Average target price
2,084.62JPY
Spread / Average Target
+22.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Olympus Corporation